This study focuses
on designing hybrid theranostic nanosystems,
utilizing gadolinium-doped carbon nanodots decorated with bioreducible
amphoteric polyamidoamines (PAAs). The objective is to synergize the
exceptional theranostic properties of gadolinium-doped carbon nanodots
(CDs) with the siRNA complexation capabilities of PAAs. Linear copolymeric
polyamidoamines, based on N,N′-bis(acryloyl)cystamine,
arginine, and agmatine, were synthesized, resulting in three distinct
amphoteric copolymers. Notably, sulfur bridges within the PAA repeating
units confer pronounced susceptibility to glutathione-mediated degradationa
key attribute in the tumor microenvironment. This pathway enables
controlled and stimuli-responsive siRNA release, theoretically providing
precise spatiotemporal control over therapeutic interventions. The
selected PAA, conjugated with CDs using the redox-sensitive spacer
cystamine, formed the CDs-Cys-PAA conjugate with superior siRNA complexing
capacity. Stable against polyanion exchange, the CDs-Cys-PAA/siRNA
complex released siRNA in the presence of GSH. In vitro studies assessed
cytocompatibility, internalization, and gene silencing efficacy on
HeLa, MCF-7, and 16HBE cell lines.